Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Brimonidine/Timolol Fixed Combination in Glaucoma/OHT
NCT00652106Phase 3Completed
- Sponsor
- Allergan
- Start
- Jun 2003
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine tartrate + timolol maleate in Glaucoma, ocular hypertension, sponsored by Allergan. Started Jun 2003; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00652106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652106.